Our principles & values, role and strategic goals
Updated on
We are dedicated to an integrated and innovative approach to cancer control, uniting all key stakeholders in France and around the world. Our shared goal is to reduce the incidence and mortality of cancer, enhance the quality of life for patients, and address health inequalities.
Our approach
- Innovation: we create value by identifying innovations at an early stage, then assessing, supporting and disseminating them to benefit both patients and the community.
- Cohesive approach: we foster an integrated approach to ensure consistency between public health efforts, cancer care organisations, and research advances.
- Shared leadership: we involve all the stakeholders in our work processes to maximise our action's impact by listening attentively and responding to each of our target groups.
- Performance: we apply a continuous improvement approach to the quality of our expertise. We conduct a systematic assessment of all our actions and their impacts.
- Forward-thinking mindset: we endeavour to anticipate and stimulate advances in all aspects of cancer control, whether scientific, medical, organisational or technological, to benefit patients.
- Service: we aim to deliver the best possible service to all: patients, their relatives, health professionals, researchers, public and institutional decision-makers, and the community as a whole.
Our role: to bring together all those involved in the fight against cancer in France
- in the health sector: learned societies, colleges, professional associations;
- in the research sector: hospital federations;
- stakeholder associations.
We share common goals:
- to reduce the incidence of preventable cancers;
- to lower cancer-related mortality;
- to improve patients’ quality of life during and after cancer;
- to reduce health inequalities in relation to cancers.
We encourage all stakeholders to take action: businesses and local authorities play key roles for patients and for health promotion. We provide them with guidance to implement their effective job retention procedures, or to implement the principle of “health in all policies”.
We steer, certify and fund stakeholders on the ground: cancer registries, canceropoles, integrated cancer research sites (SIRICs), designated early-phase centres (CLIP²), clinicobiological databases, and poor prognosis cancer research and care networks.
We coordinate the stakeholders involved in implementing the ten-year strategy:
- in the health sector: French National Authority for Health, Santé publique France, French National Agency for Medicines and Health Products Safety, regional health boards;
- in the research sector: Inserm, CNRS, French National Cancer League, ARC Foundation for Cancer Research.
Showcasing French oncology on the global stage
We are fully engaged in European strategies and projects to fight cancer. We played a key role in building the European Cancer Plan (EBCP) and are involved in over a dozen European initiatives.
As international cooperation is vital to tackling the complex challenges that affect us all, we established the “G7 Cancer” group, bringing together the world’s most advanced nations in the fight against cancer. We are also strengthening bilateral ties with leading countries like the United States and Japan, pioneers in cancer research and innovation.
Finally, we actively contribute to global organisations driving progress in oncology, such as the IARC and the ICGC—a consortium we proudly co-founded.
